Domino Liver Transplantation
Authors:
- 1 January 2012
- journal article
- review article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 18 (1) , 22-28
Abstract
Domino liver transplantation (DLT) has emerged as a strategy for increasing the number of liver grafts available: morphologically normal livers from donors with metabolic diseases can be used for select recipients with hepatocellular carcinoma (usually outside the Milan criteria). Familial amyloidotic polyneuropathy (FAP) is the most common indication for DLT. When FAP patients are involved in DLT, the indications and outcomes are clear and good, although de novo FAP development within various periods of time has been described in DLT recipients of FAP livers. With the increasing need for organs, livers explanted from patients with rare metabolic diseases, such as primary hyperoxaluria (PH), acute intermittent porphyria (AIP), maple syrup urine disease (MSUD), and homozygous familial hypercholesterolemia (HFHC), are being used for DLT. However, insufficient data about the use of livers from patients with these rare metabolic diseases are available. In this review, we focus on the latter disorders. PH is not a good indication for DLT because recipients of PH livers develop hyperoxaluria and early acute renal failure. AIP also seems to be a debatable indication for DLT because of the rapid development of neurotoxicity in AIP liver recipients. However, the outcomes of DLT with HFHC and MSUD liver grafts (which include the risk of the de novo development of these genetic diseases) are promising. For rare metabolic liver diseases to be established as indications for DLT, more reports and studies are needed.Keywords
This publication has 38 references indexed in Scilit:
- Operative Risks of Domino Liver Transplantation for the Familial Amyloid Polyneuropathy Liver Donor and Recipient: A Double AnalysisAmerican Journal of Transplantation, 2011
- Domino versus deceased donor liver transplantationLiver Transplantation, 2011
- Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantationLiver Transplantation, 2010
- Liver transplantation for inherited metabolic disorders of the liverCurrent Opinion in Organ Transplantation, 2010
- Hereditary fibrinogen A α-chain amyloidosis: phenotypic characterization of a systemic disease and the role of liver transplantationBlood, 2010
- Venoplasty of Hepatic Venous Outflow With a Venous Patch in Domino Liver TransplantationLiver Transplantation, 2008
- Transmission of Systemic Transthyretin Amyloidosis by Means of Domino Liver TransplantationNew England Journal of Medicine, 2005
- Liver transplantation as definitive treatment for a factor V Leiden mutationThe Journal of Pediatrics, 2005
- Maximum sharing of cadaver liver grafts composite split and domino liver transplantsLiver Transplantation and Surgery, 1999
- Liver Transplantation to Provide Low-Density-Lipoprotein Receptors and Lower Plasma Cholesterol in a Child with Homozygous Familial HypercholesterolemiaNew England Journal of Medicine, 1984